Being insulin-treated is one of the requirements for typical CGM devices like DexCom's G6, and not all of those ... Its current forward price-to-earnings ratio is 44, while the average for the ...

Exchange Traded Concepts LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the ...

Its products, including the Dexcom G6 and G7, aim to help people with diabetes ... reiterated a “Buy” rating on Dexcom, setting a price target of $90. As of writing, DXCM is trading below ...

Geneos Wealth Management Inc. lessened its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.6% in the ...

Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San ...

In a report released today, Jeff Johnson from Robert W. Baird upgraded Dexcom (DXCM – Research Report) to a Buy, with a price target of ...

DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $95.91, ...

Matthew Taylor, an analyst from Jefferies, reiterated the Buy rating on Dexcom (DXCM – Research Report). The associated price target remains ...

In June, DexCom announced the integration of its G6 CGM system with Insulet’s Omnipod ... They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the ...